N/A N=72 Study of Low Level Laser Therapy for Body Contouring
Body Contouring
Primary: Incidence of the Reduction of at Least 3.0 Inches Off Their Combined Waist-hips-thighs Circumference. — 21; 2 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=25 Non-Invasive Reduction of Fat in the Flanks of Patients With Sharp Body Curvature
Body Fat Disorder
Primary: Safety of the Zeltiq System for Non-invasive Fat Reduction in Subjects With Greater Flank Curvature. — 0; 0 UADEs
N/A N=68 CONFORM: Rotational Fractional Resection for Submental Contouring
Skin Laxity · Lipodystrophy
Primary: Number of Participants With a Reduction of Submental Skin Area ≥ 20 mm^2 — 49 Participants
N/A N=110 EMS for Abdominal and Gluteal Muscle Toning
Non-Therapeutic Body Modification
Primary: Change in Body Satisfaction Questionnaire From Baseline to 4-Week Post-Treatment Follow-up Visit — 5.1; 5.5 Participants completed Questionnaire
N/A N=15 Cryolipolysis for Jawline Contouring
Body Fat Disorder
Primary: Number of Participants With Unanticipated Adverse Device Effects (UADE) — 0 Participants with UADE reported
N/A N=60 Impact Of Post-Bariatric Body Contouring Procedures on Patient Body Weight and Metabolism
Bariatric Surgery Candidate
Primary: Weight Changes by Kilograms — 94.3; 96.17; 96.27; 89.4 Kilo gram
Phase 4 N=110 CoolSculpting® Elite for Non-Invasive Fat Reduction
Non-invasive Fat Reduction
Primary: Percentage of Participants With "Satisfied" or "Very Satisfied" on Item #1 for the CSQ (Cryolipolysis Satisfaction Questionnaire) - Midsection — 83.3 percentage of…
N/A N=2 The PREFORM Study: Rotational Fractional Resection for Submental Contouring
Skin Laxity · Lipodystrophy
Primary: Number of Participants Who Had at Least One Grade Improvement on the Submental Skin Laxity Scale — 2 Participants
N/A N=45 Non-Invasive Reduction of Fat in the Inner Thighs
Body Fat Disorder
Primary: Percentage of Pre-Treatment Images Correctly Identified by Reviewers — 90.5 percentage of correct identifications
N/A N=70 SlimShape Device for Abdominal Fat and Circumference Reduction
Fat Disorder
Primary: Change in Fat Thickness at Final Follow-up Compared to Baseline — -1.76 millimeters
N/A N=62 UltraShape Power for Abdominal Fat and Circumference Reduction
Excess Abdominal Fat
Primary: Change in Abdominal Fat Thickness Compared to Baseline as Measured by Ultrasound — -10.5 percentage change
N/A N=20 Evaluation of CoolSculpt Combining Venus Legacy Technology for Enhanced Results in Fat Reduction & Laxity of the Flanks
Adipose Tissue
Primary: General Improvement in Skin Laxity of the Flank Area — 1.1; 2.1 units on a scale — p=<0.01
N/A N=19 Fat Layer Reduction in the Lateral Thighs Using CoolSculpting
Body Fat Disorder
Primary: Safety of the Zeltiq CoolSculpting System in the Outer Thighs — 8; 0 events
N/A N=58 A Retrospective Analysis of the Effects of Red Light Therapy on Body Contouring
Obesity
Primary: Fat Reduction in Treatment Zone as Measured in Inches Lost — 3.5 inch
N/A N=15 DualSculpting the Abdomen Using CoolSculpting
Body Fat Disorder
Primary: Proportion of Correctly Identified Photos by Blinded Reviewers — 28 photos
N/A N=50 CoolSculpting® the Upper Arms and Inner Thighs in Participants of Chinese Descent (XinCOOL)
Body Fat Disorder
Primary: Percentage of Arms With Correct Identification of Baseline Versus 12-week Treatment Images of the Upper Arms by at Least Two Out of Three Blinded, Independent Reviewers…
N/A N=35 CoolSculpting System
Body Fat Disorder
Primary: Percentage of Photographs Correctly Identified by At Least 2 of 3 Blinded Reviewers From the Independent Physician Reviewer Panel — 75.0 % of images identified correctly
N/A N=16 VelaShape III & UltraShape Power for Thigh Circumference Reduction
Circumference Reduction
Primary: Circumference Change in the Thighs at the 12-week Follow-up Compared to Baseline Measurements — -2.8 centimeter
N/A N=60 Non-Invasive Reduction of Abdominal Fat
Fat Reduction
Primary: Proportion of Pre-treatment Images Correctly Identified — 128 photos — p=<0.001
N/A N=75 Trim II for Noninvasive Lipolysis and Circumference Reduction of Abdomen.
Circumference Reduction of Abdomen
Primary: Evaluation of Change in Abdomen Circumference Using Tape Measurements in cm at the 3 Months Follow-up Visit Comparing to Baseline. — 89.5 CM
N/A N=15 CoolSculpting Treatment in the Upper Arms
Body Fat Disorder
Primary: Proportion of Correctly Identified Pre-treatment Photos — 26 photos
Phase 3 N=793 Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)
Central Abdominal Bulging
Primary: Percentage of Subjects Who Achieved a Composite P-GAPS1/CPnS2 Response — 37; 48 Participants — p=0.397
N/A N=12 Performance Evaluation of the truSculpt Radiofrequency Device for Lipolysis of Abdominal Fat
Body Fat
Primary: Number of Participants Who's Abdominal Tissue Showed Necrosis or Inflammatory Immune Cell Response — 10; 0 Participants
N/A N=50 CoolSculpting and EMS for the Abdomen
Body Fat Disorder
Primary: Number of Unanticipated Adverse Device Effects (UADE) — 0; 0; 0; 0 events
N/A N=20 CoolSculpting in the Abdomen Using Applicator With and Without CCI
Body Fat Disorder
Primary: Percentage of Accurately Identified Pre-treatment Photos — 33; 23; 50; 23 photos
N/A N=15 Pilot Study on The Flanks of Asian Patients
Body Fat Disorder
Primary: Proportion of Pre-treatment Images Correctly Identified — 32 photos
N/A N=67 Study of the Effectiveness of Green Diode Laser Light on Body Shaping
Body Contouring
Primary: Combined Circumference in Inches of the Waist, Hips and Bilateral Thighs — -3.895; -1.136 inches
N/A N=70 Pivotal Study of the truSculpt Radiofrequency Device for Circumferential Reduction
Abdominal Fat
Primary: Difference in Circumferential Measurement Related to Sham and Therapeutic Group at 12 Weeks Post-treatment — 1.9; 0 cm
N/A N=40 CoolSculpting of the Distal Thigh Study
Body Fat Disorder
Primary: Rate of Device- or Procedure-related Adverse Events — 1 device-or procedure-related AEs
N/A N=40 Outer Thigh Study With Varied Treatment Parameters
Body Fat Disorder
Primary: Safety of the Zeltiq Device — 7; 4; 12 device/procedure related AEs